These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
49 related articles for article (PubMed ID: 3174583)
41. Inhibitor activity against elastolytic enzymes in the bronchial area. A contribution to the pathogenesis of chronic airway obstruction. Rasche B Z Erkr Atmungsorgane; 1985; 165(1):83-93. PubMed ID: 3851611 [TBL] [Abstract][Full Text] [Related]
42. [Elastase and elastase inhibitors in bronchial mucus in chronic airway obstruction with reference to therapy]. Rasche B; Hochstrasser K Prax Klin Pneumol; 1983 Oct; 37 Suppl 1():725-7. PubMed ID: 6557570 [No Abstract] [Full Text] [Related]
43. [Changes of neutrophil elastase in COPD and the role of elastase in experimental pulmonary hypertension]. Yan YZ Zhonghua Jie He He Hu Xi Za Zhi; 1988 Dec; 11(6):324-6, 384. PubMed ID: 3250749 [No Abstract] [Full Text] [Related]
44. The pathogenesis of chronic obstructive lung diseases: implications for therapy. Stockley RA QJM; 1995 Feb; 88(2):141-6. PubMed ID: 7704565 [No Abstract] [Full Text] [Related]
46. The elastase/alpha 1-proteinase inhibitor balance in the lung. A review. Virca GD; Schnebli HP Schweiz Med Wochenschr; 1984 Jun; 114(25):895-8. PubMed ID: 6379867 [TBL] [Abstract][Full Text] [Related]
47. [Lung tissue changes in irreversible airflow obstruction--emphysema and small airway disease]. Sutinen S Duodecim; 1993; 109(12):1061-9. PubMed ID: 8062677 [No Abstract] [Full Text] [Related]
48. [Anti-elastolytic inhibitory capacity and IgA deficiency--contribution to the etiopathogenesis of COPD]. Schultek T; Braun J; Wood WG; Wiessmann KJ Prax Klin Pneumol; 1988 Jun; 42 Suppl 1():307-8. PubMed ID: 3174583 [No Abstract] [Full Text] [Related]